Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 in A Two Staged, Multicenter, Open Label and Randomized Trial

NCT04333628 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.

NCT NCT04333628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 in A Two Staged, Multicenter, Open Label and Randomized Trial
Lead sponsor
HaEmek Medical Center, Israel
Phase
Phase 2/3
Overall status
Terminated
Start date
June 1, 2020
Completion date
September 1, 2020
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19